Orchestra BioMed
OBIO
OBIO
59 hedge funds and large institutions have $138M invested in Orchestra BioMed in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
6.04% more ownership
Funds ownership: 62.75% → 68.8% (+6%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
59
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$7.31M | |
| 2 | +$4.87M | |
| 3 | +$4.04M | |
| 4 |
CC
Centiva Capital
New York
|
+$3.32M |
| 5 |
WRBC
W.R. Berkley Corp
Greenwich,
Connecticut
|
+$1.98M |
Top Sellers
| 1 | -$7.5M | |
| 2 | -$5.04M | |
| 3 | -$4.29M | |
| 4 |
M
Murchinson
Toronto,
Ontario, Canada
|
-$1.98M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.13M |